Craft

Clinical Laserthermia Systems

Stock Price

KR5

2024-10-29

Market Capitalization

KR71.5 M

2024-10-29

Revenue

KR17.5 M

FY, 2025

Clinical Laserthermia Systems Summary

Company Summary

Overview
Clinical Laserthermia Systems (CLS) is a company that develops and markets medical devices for heat-induced immunotherapy enabling treatment of cancerous tumors. It provides the TRANBERG thermal therapy system and disposable materials for image-guided high precision soft tissue thermal therapy and ablation procedures.
Type
Public
Status
Active
Founded
2006
HQ
Lund, SE | view all locations
Website
https://clinicallaser.se/
Cybersecurity rating
Sectors

Key People

  • Hans Von Celsing

    Hans Von Celsing, Chairman of the Board

    • Lars-Erik Eriksson

      Lars-Erik Eriksson, Director

      • Liselotte Nilsson

        Liselotte Nilsson, VP of Marketing

      • Jimmy Johansson

        Jimmy Johansson, EVP of Operations

      LocationsView all

      4 locations detected

      • Lund, Skåne län HQ

        Sweden

        Scheelevägen 2

      • Irvine, CA

        United States

        15707 Rockfield Blvd #130

      • Irvine, CA

        United States

        5 Musick

      • Berlin, Berlin

        Germany

        Johann-Hittorf-Straße 8

      Clinical Laserthermia Systems Financials

      Summary Financials

      Revenue (Q1, 2026)
      kr1.3M
      Gross profit (Q1, 2026)
      kr861.0K
      Net income (Q1, 2026)
      (kr7.4M)
      Cash (Q1, 2026)
      kr13.0M
      EBIT (Q1, 2026)
      (kr9.6M)

      Footer menu